Important information: Past performance is no guarantee of future returns. The money invested in the fund can both increase and decrease in value and it is not certain that investors will get back the entire invested capital.
| FUND CLASS | NAV | SINCE PREVIOUS MONTH | THIS YEAR | SINCE FUND START | START DATE |
| IC1 (EUR) | 825.88 | -1.06% | -6.18% | 725.88% | 2009-06-22 |
| IC3 (EUR) | 1035.63 | -0.99% | -5.71% | 935.63% | 2009-07-31 |
| IC2 (SEK) | 645.80 | 1.80% | -2.23% | 545.80% | 2012-12-31 |
| ID1 (SEK)Distributing | 404.74 | 1.75% | -6.83% | 304.74% | 2012-04-30 |
| IC1 (USD) | 185.80 | -2.46% | -17.02% | 85.80% | 2015-01-31 |
| IC2 (USD) | 255.15 | -2.42% | -16.74% | 155.15% | 2014-04-30 |
| RC1 (EUR) | 709.66 | -1.10% | -6.52% | 609.66% | 2010-08-31 |
| RC1 (SEK) | 757.76 | 1.70% | -2.91% | 657.76% | 2009-06-22 |
| RC2 (SEK) | 803.05 | 1.75% | -2.58% | 703.05% | 2009-06-22 |
Rhenman Healthcare Equity L/S
("RHE L/S")
RHE L/S is a global, long-biased hedge fund that invests in the healthcare sector. Since RHE L/S was launched in June 2009, it has returned + 726 %, which corresponds to an annual average of + 17 %. RHE L/S is managed by an experienced management team and supported by the Scientific Advisory Board. Read more >
Rhenman & Partners Asset Management
Founded in 2008, Rhenman & Partners Asset Management is a Stockholm-based asset manager focusing on managing the portfolio of a niche fund that is registered in Luxembourg: Rhenman Healthcare Equity L/S (RHE L/S), launched in 2009. The fund is managed by FundRock Management Company SA., who have commissioned Rhenman & Partners Asset Management to manage the fund's portfolio. Read more >
The portfolio managers Henrik and
Susanna discuss the healthcare fund
Rhenman Healthcare Equity L/S is celebrating its 10-year anniversary, and the fund’s two portfolio managers talk about the fund’s strategy, focus and expectations. The fund has returned an average of +17 % per annum during the 10 years RHE L/S has been active. Susanna highlights four areas that explain this success. Henrik shares his thoughts on the future of the healthcare sector and what to expect from the fund in the coming years.
Keep up-to-date
Keep yourself updated by reading our monthly letter: Rhenman Healthcare Equity L/S. Read more >
The Scientific Advisory Board
An important reason behind our fund's great success is the co-operation between the portfolio managers and the medical experts on our Scientific Advisory Board. Read more >
Rhenman Healthcare Equity L/S
Fund development - IC1 (EUR)Important information: Past performance is no guarantee of future returns. The money invested in the fund can both increase and decrease in value and it is not certain that investors will get back the entire invested capital.
For several decades, the healthcare sector has accounted for a rising share of the world’s GDP. In the US, the share has risen to 19%. In the OECD countries, the average is 12%. In emerging markets, such as China and India, shares of GDP are rising quickly, which means there is great potential. Read more >
Read more >
Latest news
- 30 September 2022 Teresa Isele to be the new CEO of Rhenman & Partners Asset Management AB
- 12 May 2022 Rhenman & Partners winner of Refinitiv Lipper Fund Awards Nordics
- 17 November 2021 Susanna Urdmark included in The Hedge Fund Journal’s “50 Leading Women in Hedge Funds 2021”
- 07 May 2021 EUROPEAN FUND MANAGER INSIGHTS 2021 - Specialist managers in a favourable position
- 12 March 2021 RHE L/S winner of Hedgeweek European Awards 2021: Best Global Equity Hedge Fund